Home Infusion Pain Management
Customize your policy alerts
Sign up for University Health Alliance (HSA) Policy MPP-0094-121120 alerts
Get alerted when Policy MPP-0094-121120 changes without checking for updates manually.
Monitor payer policy activity
This document governs reimbursement and medical necessity criteria for home infusion therapy for pain management provided to University Health Alliance members, including covered indications, limitations, prior authorization and administrative requirements.
No material clinical or coverage changes in this revision.
Coverage and Medical Necessity Criteria
Coverage criteria
Covered when ALL of the following are met:
ALL of the following
Indication
- Patient with terminal cancer when pain is unresponsive to standard pain management interventions or when rapid onset of analgesia and a sustained consistent level of drug is needed to prevent pain.
- Patient with chronic, nonmalignant pain.
- Drugs delivered via home infusion are FDA‑approved for the indicated route of administration.
- Patient is homebound to qualify for coverage (a 1–2 day inpatient stay may be medically necessary for a preliminary trial of intraspinal opioid drug administration).
- Uses appropriate modality of home infusion (e.g., IV PCA, epidural or intrathecal infusion) with documentation that less invasive administration routes are no longer effective or appropriate.
Conservative treatment requirements
Required before initiating home infusion for chronic or severe pain:
ALL of the following
- Documentation of failed prior routes/attempts: clinical record shows that pain was not effectively controlled with non‑invasive methods such as systemic opioids and other standard pain management interventions, or there is an acute exacerbation requiring short‑term adjunctive therapy (2–3 weeks).
- Evaluation by a multidisciplinary team prior to initiation, with documentation of that evaluation in the medical record.
- Treatment must be initiated and monitored by a board‑certified anesthesiologist, neurologist, or pain medicine specialist.
Coding and Procedure Notes
| No codes listed |
Key Definitions
Prior Conservative Treatments and Specialist Involvement
Conservative treatment requirements
Required before and during home infusion therapy:
ALL of the following
- Documented evidence of failure of previous pain control regimens by other routes of administration for chronic nonmalignant pain (or documentation supporting use for terminal cancer or short‑term acute exacerbation).
- Multidisciplinary team evaluation documented in the medical record prior to initiation of home infusion therapy.
- Ongoing initiation and monitoring of therapy by a board‑certified anesthesiologist, neurologist, or pain medicine specialist with appropriate follow‑up visits documented.
Administrative and Provider Requirements
Prior authorization required; submit via UHA online portal
Prior authorization is required for home infusion pain management. Submit prior authorization requests via UHA's online portal; if you do not have a login, contact UHA at 808-532-4000 to establish one.
- Submit requests through UHA's online portal
- Call 808-532-4000 to establish a portal login if needed
Retrospective review may be performed; providers may request reconsideration
UHA may perform retrospective review to validate that services rendered met the payment determination criteria. A provider may request that UHA reconsider the application of the medical necessity criteria by submitting supporting documentation.
- UHA reserves the right to perform retrospective review using the policy criteria to validate services
- Providers may request reconsideration with supporting documentation if they disagree with application of the medical necessity criteria
Allowed Duration and Frequency Limits
Imaging and Diagnostic Requirements
Imaging: none required by this policy
No imaging requirements are specified for home infusion or implantable pump placement in this policy.
Non-Covered Situations
Home infusion pain management is not covered in the following situations: when the patient is noncompliant with treatment and follow‑up with the prescribing physician or has a documented history of noncompliant behavior; when clinical data, tests, and symptoms indicate that home infusion is no longer effective; when the drugs or routes of administration are not FDA‑approved; or when there is no meaningful documentation of failure of previous pain control regimens by other routes of administration for patients with chronic, nonmalignant pain.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.